[HTML][HTML] A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
M Lübbert, BH Rüter, R Claus, C Schmoor… - …, 2012 - ncbi.nlm.nih.gov
Background The treatment of acute myeloid leukemia of older, medically non-fit patients still
poses a highly unmet clinical need, and only few large, prospective studies have been …
poses a highly unmet clinical need, and only few large, prospective studies have been …
[引用][C] A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
M LÜBBERT, BH RÜTER, O GALM… - Haematologica …, 2012 - pascal-francis.inist.fr
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute
myeloid leukemia judged unfit for induction chemotherapy CNRS Inist Pascal-Francis CNRS …
myeloid leukemia judged unfit for induction chemotherapy CNRS Inist Pascal-Francis CNRS …
[引用][C] A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
M Lubbert, BH Ruter, R Claus, C Schmoor… - 2012 - opus.bibliothek.uni-augsburg.de
OPUS 4 | A multicenter phase II trial of decitabine as first-line treatment for older patients with
acute myeloid leukemia judged unfit for induction chemotherapy Deutsch Login Open Access …
acute myeloid leukemia judged unfit for induction chemotherapy Deutsch Login Open Access …
[PDF][PDF] A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
M Lübbert, BH Rüter, R Claus, C Schmoor… - …, 2012 - researchgate.net
Background The treatment of acute myeloid leukemia of older, medically non-fit patients still
poses a highly unmet clinical need, and only few large, prospective studies have been …
poses a highly unmet clinical need, and only few large, prospective studies have been …
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
M Lübbert, BH Rüter, R Claus, C Schmoor… - …, 2012 - pubmed.ncbi.nlm.nih.gov
Background The treatment of acute myeloid leukemia of older, medically non-fit patients still
poses a highly unmet clinical need, and only few large, prospective studies have been …
poses a highly unmet clinical need, and only few large, prospective studies have been …
[PDF][PDF] A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
M Lübbert, BH Rüter, R Claus, C Schmoor… - …, 2012 - academia.edu
Background The treatment of acute myeloid leukemia of older, medically non-fit patients still
poses a highly unmet clinical need, and only few large, prospective studies have been …
poses a highly unmet clinical need, and only few large, prospective studies have been …
[HTML][HTML] A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
M Lübbert, BH Rüter, R Claus, C Schmoor… - …, 2012 - haematologica.org
Background The treatment of acute myeloid leukemia of older, medically non-fit patients still
poses a highly unmet clinical need, and only few large, prospective studies have been …
poses a highly unmet clinical need, and only few large, prospective studies have been …
[引用][C] A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
M Luebbert, BH Rueter, R Claus, C Schmoor… - 2012 - oparu.uni-ulm.de
DNA hypomethylation, medically non-fit patients, comorbidities, decitabine, DAC, trans-
retinoic acid, risk myelodysplastic syndrome, southwest-oncology-group, low-dose …
retinoic acid, risk myelodysplastic syndrome, southwest-oncology-group, low-dose …
[引用][C] A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
M LUBBERT - Haematologica, 2012 - cir.nii.ac.jp
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute
myeloid leukemia judged unfit for induction chemotherapy | CiNii Research CiNii 国立情報学 …
myeloid leukemia judged unfit for induction chemotherapy | CiNii Research CiNii 国立情報学 …
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy.
M Lübbert, BH Rüter, R Claus, C Schmoor… - …, 2011 - europepmc.org
Background The treatment of acute myeloid leukemia of older, medically non-fit patients still
poses a highly unmet clinical need, and only few large, prospective studies have been …
poses a highly unmet clinical need, and only few large, prospective studies have been …